y.ramos
TL2 Moderator · Plovdiv
Contributes reviews on supplier material. Based in Plovdiv.
Joined 23 December 2024 · last posted 2d
85Posts here
3Topics
0Solutions
753Likes received
1.2kLikes given
25Badges
205Days visited
3.4kPosts read
Most-liked posts
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #16 · Compounds › Semaglutide · 16 Sep 2025 · 33 likes I read post #14 twice before replying, because I had assumed the opposite. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology…
-
Journal club: semaglutide in MASH, and surrogate endpoints Replied, post #22 · Evidence › Journal club · 8 Jun 2026 · 30 likes I read post #20 twice before replying, because I had assumed the opposite. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #76 · Sourcing › Regulatory · 26 Jul 2026 · 29 likes Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds with no human data are being used on theoretical grounds. The…
-
Reading order for a first week here, and what to skip until later Replied, post #50 · Start Here › Welcome · 24 Mar 2025 · 29 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #7 · Documentation › Doc review · 31 Jan 2025 · 29 likes Coming back to post #5, because the follow-up matters more than the original answer. Evidence synthesis requests: if you think a page should summarise the state of…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #67 · Compounds › Tirzepatide · 3 Dec 2024 · 27 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
Where this member posts
| Category | Posts | Share |
|---|---|---|
| Compounds | 14 | 16% |
| Practice | 13 | 15% |
| Sourcing | 9 | 11% |
| Start Here | 6 | 7% |
| Pharmacology | 5 | 6% |
| Meta | 5 | 6% |
Badges earned, in order
| Badge | Tier | Granted |
|---|---|---|
| Read the Guidelines | bronze | 24 Dec 2024 |
| Basic User | bronze | 26 Dec 2024 |
| First Link | bronze | 28 Dec 2024 |
| First Reply | bronze | 30 Dec 2024 |
| First Topic | bronze | 1 Jan 2025 |
| First Quote | bronze | 10 Jan 2025 |
| Welcome | bronze | 11 Jan 2025 |
| Generous | bronze | 12 Jan 2025 |
| Asked Well | bronze | 13 Jan 2025 |
| Member | bronze | 16 Feb 2025 |
| Editor | bronze | 17 Feb 2025 |
| First Tag | bronze | 20 Feb 2025 |
| Reader | bronze | 20 Feb 2025 |
| Sourced | bronze | 27 Mar 2025 |
| Thank You | silver | 2 Apr 2025 |
| Consistently Generous | silver | 10 Apr 2025 |
| Nice Post | bronze | 24 May 2025 |
| Promoted | silver | 24 May 2025 |
| Nice Topic | bronze | 29 Jun 2025 |
| First Vendor Report | bronze | 3 Jul 2025 |
| Good Topic | silver | 25 Aug 2025 |
| Good Post | silver | 2 Sep 2025 |
| Popular Link | silver | 5 Oct 2025 |
| De-escalator | gold | 15 Nov 2025 |
| Anniversary | silver | 23 Dec 2025 |